title: Feasibility of percutaneous transluminal coronary angioplasty to patients with Kawasaki Disease as an early management strategy.
abstract: We successfully performed percutaneous transluminal coronary angioplasty (PTCA) in three infants with Kawasaki disease ages 11 to 29 months. The time from the onset of disease to PTCA ranged from 6 to 21 months. On period reevaluation 12 to 40 months after PTCA, they had no evidence of myocardial ischemia or restenosis. As an early management strategy, PTCA could be a good palliation to control myocardial ischemia associated with Kawasaki disease. From our study and a literature review, we suggest that PTCA may be more effective if it is performed earlier, even in young patients.
authors.affiliation: Department of Pediatrics, Nippon Medical School Chiba Hokusoh Hospital, 1715 Kamagari, Inba, Chiba 270-16, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kuramochi
authors.forename: T
authors.initials: T
authors.lastname: Ohkubo
authors.forename: N
authors.initials: N
authors.lastname: Takechi
authors.forename: S
authors.initials: S
authors.lastname: Ogawa
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications*; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy*